Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid
Wen-Yan Wang,Wen-Yi Wu,A-Liang Li,Qing-Song Liu,Yue Sun,Wen Gu
DOI: https://doi.org/10.1016/j.bioorg.2021.104705
IF: 5.307
2021-04-01
Bioorganic Chemistry
Abstract:<p>A series of novel indolequinone derivatives of ursolic acid bearing ester, hydrazide, or amide moieties were designed, synthesized, and screened for their <em>in vitro</em> antiproliferative activities against three cancer cell lines (MCF-7, HeLa, and HepG2) and a normal gastric mucosal cell line (Ges-1). A number of compounds showed significant activity against tested cancer cell lines. Among them, compound <strong>6t</strong> exhibited the most potent activity against three cancer cell lines with IC<sub>50</sub> values of 1.66 ± 0.21, 3.16 ± 0.24, and 10.35 ± 1.63 µM, respectively, and considerably lower cytotoxicity to Ges-1 cells. Especially, compound <strong>6t</strong> could arrest cell cycle at S phase, suppress the migration of MCF-7 cells, elevate intracellular reactive oxygen species (ROS) level, and decrease mitochondrial membrane potential. Western blot analysis showed that compound <strong>6t</strong> upregulated Bax, cleaved caspase-3/9, cleaved PARP levels and downregulated Bcl-2 level of MCF-7 cells. All these results indicated that compound <strong>6t</strong> could significantly induce the apoptosis of MCF-7 cells. Meanwhile, compound <strong>6t</strong> markedly decreased p-AKT and p-mTOR expression, which revealed that compound <strong>6t</strong> probably exerted its cytotoxicity through targeting PI3K/AKT/mTOR signaling pathway. Therefore, compound <strong>6t</strong> could be a promising lead for the discovery of novel anticancer agents.</p>
biochemistry & molecular biology,chemistry, organic